The novel treatment of the medication represents a significant advance in the management of diabetes mellitus type 2. Distinct from existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 https://tirzepatidepeptide399405.gynoblog.com/40714322/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment